Search results
Results from the WOW.Com Content Network
Acute severe asthma, also known as status asthmaticus, is an acute exacerbation of asthma that does not respond to standard treatments of bronchodilators (inhalers) and corticosteroids. [2] Asthma is caused by multiple genes , some having protective effect, with each gene having its own tendency to be influenced by the environment although a ...
Acute severe asthma, previously known as status asthmaticus, is an acute exacerbation of asthma that does not respond to standard treatments of bronchodilators and corticosteroids. [115] Half of cases are due to infections with others caused by allergen, air pollution, or insufficient or inappropriate medication use. [115]
Epinephrine is the generic name of the drug and its INN Tooltip International Nonproprietary Name and USAN Tooltip United States Adopted Name, while adrenaline is its BAN Tooltip British Approved Name. [62] [63] [64] Epinephrine is sold under various brand names including Asthmanefrin, Micronefrin, Neffy, Nephron, VapoNefrin, and Primatene Mist ...
Status asthmaticus or other acute episodes of asthma which would require intensive, immediate measures. [37] [41] In Canada, there are additional contraindications labeled for Budesonide for people with: Systemic or local bacterial, fungal and viral infections. [37] Active or quiescent pulmonary tuberculosis. [37]
Medications, including aspirin, [14] β-adrenergic antagonists (beta blockers), [15] ibuprofen, and penicillin. [16] Food allergies such as milk, peanuts, and eggs. However, asthma is rarely the only symptom, and not all people with food or other allergies have asthma [17]
These drugs are used for the treatment of asthma. They may be useful either in the treatment or prevention of asthma attacks. Subcategories.
olodaterol: approved in some European countries and Russia, and by the U.S. Food and Drug Administration (FDA) on July 31, 2014, under Striverdi Respimat [13] vilanterol is the ultra-LABA not available by itself but only as a component of combination drugs: with fluticasone furoate: Breo Ellipta , Relvar Ellipta (EU, RU).
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).